HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Inter Parfums Q3 sales

This article was originally published in The Rose Sheet

Executive Summary

Net sales in the third quarter grew 15% to $77.2 mil., boosted by Burberry fragrance sales, which continued to perform strongly despite a difficult comparison to the prior year period, in which Burberry Brit for Men launched, company reports Oct. 17. Lanvin Eclat d'Arpège and "to a lesser extent" the debut of Christian LaCroix Tumulte and Celine Fever contributed to the gain, Inter Parfums adds. Firm anticipates continued strong sales in Q4, bolstered by the launch of Burberry Brit Gold and Lanvin Arpege Pour Homme this fall(1"The Rose Sheet" Oct. 3, 2005, p. 7). For the nine-month period, revenues advanced 22% to $210 mil. Inter Parfums will release Q3 operating results the week of Nov. 7...

You may also be interested in...

Inter Parfums

Due to a reassignment of certain items from the third fiscal quarter to the fourth quarter, net sales in Q3 are revised to approximately $75.5 mil., a decrease from the previously released $77.2 mil. figure, fragrance manufacturer and distributor announces Oct. 31. "The revision to net sales was a result of timing only," company notes. For the nine-month period, sales were approximately $207.9 mil., not $210 mil. as previously stated, according to the company. Sales numbers were originally released Oct. 17 (1"The Rose Sheet" Oct. 24, 2005, In Brief). Firm reaffirms 2005 sales guidance of approximately $274 mil. and net income of $14.6 mil...

Procter & Gamble Prestige To Distribute New Lanvin, Burberry Scents

Arpège pour Homme by Lanvin is a reinterpretation of the Lanvin brand with a modern, refined positioning, according to Procter & Gamble Prestige Products, which distributes the line in the U.S. for licensee Inter Parfums

Sanofi Bets Big On IO With Synthorx Buy

The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts